Reported 6 days ago
The tequila industry, including Kendall Jenner's 818 Tequila, is experiencing signs of market normalization after years of growth, with decreased consumer spending and increased caution in purchases. The sector, suffering from oversupply and potential tariffs, is witnessing layoffs and a shift towards more affordable quality options. Brands like Pantalones are adjusting strategies, focusing on core products and expanding into new markets like the UK while navigating an uncertain economic landscape.
Source: YAHOO
Reported 6 days ago
China has announced anti-dumping duties reaching up to 74.9% on imports of POM copolymers, a type of engineering plastic, from the United States, EU, Japan, and Taiwan. This decision follows a probe initiated after the U.S. raised tariffs on Chinese goods, and the new duties vary from 34.5% on EU imports to 35.5% on Japanese products, while Taiwan faces a general rate of 32.6%. This move comes amid attempts to ease trade tensions between the U.S. and China.
Source: YAHOO
Reported 6 days ago
Source: BARRONS
Reported 6 days ago
According to CATL's chairman, Zeng Yuqun, up to 50% of heavy truck sales in China could shift to electric vehicles (EVs) by 2028, increasing from just 10% in 2024. This trend highlights growing challenges for fuel demand in the trucking sector, particularly affected by the rise of LNG trucks. CATL is also expanding its manufacturing capabilities in Shandong, aiming to create a major battery industry cluster worth billions.
Source: YAHOO
Reported 6 days ago
Moody's recent downgrade of the U.S. credit rating has heightened investor fears over the country's escalating debt, currently at $36 trillion. Amid ongoing discussions in Congress over a substantial tax and spending bill, the downgrade serves as a warning of potential higher borrowing costs and the risk of further fiscal irresponsibility. While the White House downplays the concerns, experts suggest the bill could significantly increase the nation's debt, leading to continued anxieties in the bond market.
Source: YAHOO
Reported 6 days ago
Source: WSJ
Reported 6 days ago
Source: WSJ
Reported 6 days ago
Warren Buffett's Berkshire Hathaway sold 1,145,938 shares of DaVita Inc. for $168.58 million just a day before a lawsuit was filed against the company for allegedly inflating treatment costs and colluding to avoid competition. Despite this sell-off, DaVita remains a significant part of Buffett's portfolio, valued at over $5 billion, and has shown strong performance in the stock market.
Source: YAHOO
Reported 6 days ago
Robert Kiyosaki, the author of Rich Dad Poor Dad, has made a bold new Bitcoin prediction, forecasting it will reach $250,000 by the end of 2025, despite its current price of $103,278. Kiyosaki attributes his bullish outlook to concerns over what he describes as a failing financial system driven by central banks, which he considers 'Marxist.' He encourages followers to buy more Bitcoin and views it, along with gold and silver, as a safeguard against inflation and financial mismanagement.
Source: YAHOO
Reported 7 days ago
Several Chinese firms are planning to list in Singapore over the next 12 to 18 months as they seek to broaden their markets amid ongoing U.S.-China trade disputes. This includes various sectors such as energy and healthcare. Singapore's stock exchange aims to boost its attractiveness for listings, especially as Chinese businesses look to establish a presence in Southeast Asia. Despite this interest, challenges remain as Hong Kong continues to dominate in new listings.
Source: YAHOO
Reported 7 days ago
Eli Lilly and Company has partnered with Rznomics to develop RNA-based therapies for sensorineural hearing loss, with milestone payments exceeding $1.3 billion. Rznomics will focus on early research while Lilly handles clinical development and commercialization. This collaboration complements Lilly's existing gene therapy efforts targeting hearing loss, including a promising therapy aimed at OTOF gene mutations. Industry interest in genetic hearing loss is growing, with recent studies showing significant improvements in hearing for pediatric patients.
Source: YAHOO
Reported 7 days ago
President Trump has publicly criticized Walmart for warning consumers about potential price increases due to tariffs, insisting that the company should absorb the costs. Walmart's CEO highlighted that high tariffs prevent them from maintaining low prices on items such as toys and specific foods. As other companies also express concerns about rising prices, Walmart's CFO predicts consumers will begin seeing price hikes soon.
Source: YAHOO
Reported 7 days ago
Germany does not anticipate UniCredit pursuing a full bid for Commerzbank currently, according to Chancellor Friedrich Merz. Although UniCredit holds a 28% stake in Commerzbank and has European Central Bank approval to increase it to 29.9%, it views this stake merely as a financial investment. Merz emphasized that the share percentage is below the level needed to trigger a takeover offer and that he has not discussed the situation with Italian Prime Minister Giorgia Meloni.
Source: YAHOO
Reported 7 days ago
During President Trump's recent Middle East trip, which included stops in Saudi Arabia, Qatar, and the UAE, he met with over 60 CEOs, blending business interests with diplomatic efforts. Prominent figures such as Sam Altman of OpenAI and Jensen Huang of Nvidia were present at various gatherings aimed at boosting investment, particularly in artificial intelligence and technology. Trump emphasized a vision of commerce over chaos for the region and proposed lifting restrictions on AI exports. However, the trip raised ethical concerns about the intertwining of his business dealings with official duties, especially as he fostered relations that could benefit his own business interests.
Source: YAHOO
Reported 7 days ago
U.S. stocks are climbing back towards record highs, with the S&P 500 just 3% short of its peak from mid-February, following a dramatic recovery from a recent market crash triggered by President Trump's tariffs. Analysts express optimism, suggesting the market could surprise with new highs, citing better-than-expected inflation and improving trade negotiations. However, warnings remain about the fragility of the rally as challenges from ongoing tariffs and economic impacts loom.
Source: YAHOO
Reported 7 days ago
Oppenheimer has increased its price target for Acadia Pharmaceuticals (ACAD) from $17 to $19 while maintaining a Perform rating on the stock. The decision follows a Delaware court ruling that confirmed Acadia's patent protection for Nuplazid, alleviating concerns about potential legal issues and shifting investor focus back to the company's upcoming developments.
Source: YAHOO
Reported 7 days ago
BMO Capital analyst Evan Seigerman highlights that a recent U.S. district court ruling favored Acadia Pharmaceuticals in a patent infringement case against Aurobindo, confirming that Aurobindo violated key claims of Acadia’s patent. This ruling could extend the patent protection for Acadia’s drug, pimavanserin, from 2030 to 2038, thereby removing a significant uncertainty for investors and maintaining an Outperform rating with a $24 price target on Acadia shares.
Source: YAHOO
Reported 7 days ago
Nvidia has announced that it will not send GPU designs to China, countering a report about its plans to establish a research and development center in Shanghai. This decision follows concerns about compliance with export controls, made clear by a company spokesperson. Meanwhile, Google has overtaken IBM as the leader in generative AI-related patents, and Anthropic has secured a $2.5 billion revolving credit line to enhance its liquidity in the competitive AI landscape.
Source: YAHOO
Reported 7 days ago
ZIM Integrated Shipping Services has seen a surge in call volume, with 14,787 options traded, 1.4 times the expected amount. The implied volatility has also increased significantly. The most active options include the weekly 20 calls and May-25 18 calls, with earnings anticipated on May 19th.
Source: YAHOO
Reported 7 days ago
Leerink analyst Joseph Schwartz has a positive outlook on BioMarin following its acquisition of Inozyme Pharma for $270 million, believing the deal could yield substantial revenue from the newly added INZ-701 therapy. The acquisition aligns with BioMarin's growth strategy and expertise in enzyme replacement therapies, suggesting that more business development deals may follow. Leerink maintains an Outperform rating on BioMarin's shares.
Source: YAHOO
Reported 7 days ago
Source: BARRONS
Reported 7 days ago
BofA has reduced its price target for Bank of Montreal (BMO) from C$150 to C$149 while maintaining a Neutral rating. This adjustment is attributed to a slowdown in the Canadian economy, characterized by a weak housing market and sluggish private sector job growth, which may delay the peak in the credit cycle. However, potential policy changes from the new administration and easing trade tensions with the U.S. could improve growth sentiment.
Source: YAHOO
Reported 7 days ago
BofA has increased its price target for Scotiabank (BNS) from C$70 to C$71 while maintaining a Neutral rating on the shares. The firm notes that the anticipated cyclical recovery in the Canadian economy is being hindered by a weak housing market and slow job growth. This may delay the peak in the credit cycle, although potential policy changes from the new Carney administration and easing trade tensions with the U.S. could improve growth sentiment.
Source: YAHOO
Reported 7 days ago
BofA analyst Ebrahim Poonawala has raised the price target for CIBC from C$98 to C$100, maintaining a Buy rating. The expected rebound in the Canadian economy has faced challenges due to a weak housing market and slow job growth. Potential policy actions from the new Carney administration and improved U.S. trade relations may enhance growth outlook.
Source: YAHOO
Reported 7 days ago
Morgan Stanley has downgraded Mediobanca from Overweight to Equal Weight, raising its price target from EUR 21 to EUR 22. The bank's share price has surged approximately 50% since the beginning of the year, prompting the analysts to believe that its current valuation is fair.
Source: YAHOO